Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

Details for Australian Patent Application No. 2004206844 (hide)

Owner Teva Pharmaceutical Industries, Ltd.

Inventors Cohen-Vered, Sharon; Naftali, Esmira; Weinstein, Vera; Gilbert, Adrian; Klinger, Ety

Agent FB Rice

Pub. Number AU-A-2004206844

PCT Pub. Number WO2004/064788

Priority 60/439,950 14.01.03 US

Filing date 14 January 2004

Wipo publication date 5 August 2004

International Classifications

A61K 038/00 Medicinal preparations containing peptides

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/064788 Priority application(s): WO2004/064788

5 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004206846-Quaternary antimuscarinic compounds for the treatment of bladder diseases

2004206842-Parenteral formulations of peptides for the treatment of systemic lupus erythematosus